首页 > 最新文献

Annals of Allergy Asthma & Immunology最新文献

英文 中文
Master Clinician: How I Diagnose IgE-Mediated Food Allergy. 临床大师:我是如何诊断 IgE 导致的食物过敏的?
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-10 DOI: 10.1016/j.anai.2024.10.027
Matthew Greenhawt
{"title":"Master Clinician: How I Diagnose IgE-Mediated Food Allergy.","authors":"Matthew Greenhawt","doi":"10.1016/j.anai.2024.10.027","DOIUrl":"https://doi.org/10.1016/j.anai.2024.10.027","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of 5-domain rhinology-focused symptom score with dupilumab in chronic rhinosinusitis with nasal polyps. 在慢性鼻窦炎伴鼻息肉患者中使用杜普鲁单抗进行五域鼻科症状评分。
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-10 DOI: 10.1016/j.anai.2024.11.001
Kirsten Stewart, Chris RuiWen Kuo, Rory Chan, Brian Lipworth
{"title":"Performance of 5-domain rhinology-focused symptom score with dupilumab in chronic rhinosinusitis with nasal polyps.","authors":"Kirsten Stewart, Chris RuiWen Kuo, Rory Chan, Brian Lipworth","doi":"10.1016/j.anai.2024.11.001","DOIUrl":"10.1016/j.anai.2024.11.001","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2024-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142632216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunology 133 (2024) 286-94]>. 对......的更正
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-02 DOI: 10.1016/j.anai.2024.10.023
Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, Timothy E Dribin, Elissa M Abrams, Aikaterini Anagnostou, Kimberly G Blumenthal, Mark Boguniewicz, Nicole M Chase, David B K Golden, Nicholas L Hartog, Jennifer R Heimall, Tina Ho, Monica G Lawrence, David A Khan, Timothy Dean Minniear, S Shahzad Mustafa, John J Oppenheimer, Elizabeth J Phillips, Allison Ramsey, Nicholas L Rider, Lynda Schneider, Marcus S Shaker, Jonathan M Spergel, Cosby A Stone, David R Stukus, Julie Wang, Matthew J Greenhawt
{"title":"Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunology 133 (2024) 286-94]>.","authors":"Jay A Lieberman, Derek K Chu, Tasnuva Ahmed, Timothy E Dribin, Elissa M Abrams, Aikaterini Anagnostou, Kimberly G Blumenthal, Mark Boguniewicz, Nicole M Chase, David B K Golden, Nicholas L Hartog, Jennifer R Heimall, Tina Ho, Monica G Lawrence, David A Khan, Timothy Dean Minniear, S Shahzad Mustafa, John J Oppenheimer, Elizabeth J Phillips, Allison Ramsey, Nicholas L Rider, Lynda Schneider, Marcus S Shaker, Jonathan M Spergel, Cosby A Stone, David R Stukus, Julie Wang, Matthew J Greenhawt","doi":"10.1016/j.anai.2024.10.023","DOIUrl":"https://doi.org/10.1016/j.anai.2024.10.023","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abstract Issue Title Page 摘要 期刊标题页
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/S1081-1206(24)01650-8
{"title":"Abstract Issue Title Page","authors":"","doi":"10.1016/S1081-1206(24)01650-8","DOIUrl":"10.1016/S1081-1206(24)01650-8","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 6","pages":"Page S1"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142573414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The intersection of food allergy and food insecurity in post-secondary institutions 中学后教育机构中食物过敏与食物不安全的交叉问题。
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/j.anai.2024.08.030
Jennifer L.P. Protudjer PhD
{"title":"The intersection of food allergy and food insecurity in post-secondary institutions","authors":"Jennifer L.P. Protudjer PhD","doi":"10.1016/j.anai.2024.08.030","DOIUrl":"10.1016/j.anai.2024.08.030","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 5","pages":"Pages 499-500"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for Readers 读者信息
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/S1081-1206(24)01539-4
{"title":"Information for Readers","authors":"","doi":"10.1016/S1081-1206(24)01539-4","DOIUrl":"10.1016/S1081-1206(24)01539-4","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 5","pages":"Page A5"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142571357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Dose Dependent: A Case report of NSAID-induced urticaria and angioedema in an otherwise asymptomatic individual [M058]” (Ann Allergy Asthma Immunol. 2023; 131(5S1): S114) 更正:"剂量依赖性:非甾体抗炎药物诱发无症状个体荨麻疹和血管性水肿的病例报告 [M058]》(Ann Allergy Asthma Immunol.2023; 131(5S1):S114)
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/j.anai.2024.06.026
S. Majid, Y. Hamzavi-Abedi
{"title":"Correction to “Dose Dependent: A Case report of NSAID-induced urticaria and angioedema in an otherwise asymptomatic individual [M058]” (Ann Allergy Asthma Immunol. 2023; 131(5S1): S114)","authors":"S. Majid,&nbsp;Y. Hamzavi-Abedi","doi":"10.1016/j.anai.2024.06.026","DOIUrl":"10.1016/j.anai.2024.06.026","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 5","pages":"Page 618"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141841523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes associated with prehospital epinephrine in adult and pediatric patients with anaphylaxis 成人和儿童过敏性休克患者院前注射肾上腺素的相关结果。
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/j.anai.2024.08.006
Andrea L. Hlady MD, PhD , Aliza F. Weinman MD, MPH , Yuedan Zhang MD , Aidan F. Mullan MA , Ronna L. Campbell MD, PhD

Background

Prompt epinephrine administration is important to improve outcomes in anaphylaxis.

Objective

To assess the impact of prehospital epinephrine on clinical outcomes of hospital admission, biphasic reactions, and emergency department (ED) length of stay (LOS) in a cohort of ED patients who had anaphylaxis including both children and adults.

Methods

We conducted a single-center prospective and retrospective cohort study of patients who had anaphylaxis from April 2008 to December 2022. Associations between prehospital epinephrine administration with biphasic reactions and ED LOS were assessed with univariable models and the association with ED disposition was assessed with both univariable and multivariable logistic regression.

Results

A total of 1107 patient visits were included for analysis. The median patient age was 29 (IQR: 14-50), 593 (53.6%) patients were of female sex, and 366 (33.1%) were younger than 18 years of age. Patients in the prehospital epinephrine group were also less likely to experience a biphasic reaction (5.4% vs 9.3%; odds ratio [OR] 0.56, 95% CI: 0.34-0.92) and had a decreased ED LOS (median 4.0 hours vs 4.7 hours). There was no difference in hospital admission between patients with and without prehospital epinephrine in both the univariable (19.5% vs 15.7%; OR 1.30, 95% CI: 0.94-1.79) and multivariable (adjusted OR 1.08, 95% CI: 0.71-1.64) models.

Conclusion

Prehospital epinephrine administration reduced the odds of a biphasic reaction and decreased ED LOS but did not reduce hospitalization in this cohort of ED patients who had anaphylaxis. Our findings suggest that timely administration of prehospital epinephrine is associated with improved patient outcomes.
背景:及时注射肾上腺素对改善过敏性休克的预后非常重要:及时注射肾上腺素对改善过敏性休克的预后非常重要:我们的研究旨在评估院前肾上腺素对包括儿童和成人在内的一组急诊室过敏性休克患者入院、双相反应和急诊室住院时间(LOS)等临床结果的影响:我们对 2008 年 4 月至 2022 年 12 月期间的过敏性休克患者进行了一项单中心前瞻性和回顾性队列研究。通过单变量模型评估了院前肾上腺素给药与双相反应和急诊室住院时间之间的关系,并通过单变量和多变量逻辑回归评估了与急诊室处置之间的关系:共纳入 1107 次患者就诊进行分析。患者年龄中位数为 29 岁(IQR 14-50),593 名(53.6%)患者为女性,366 名(33.1%)患者未满 18 岁。院前肾上腺素组患者发生双相反应的几率也较低(5.4% 对 9.3%;OR 0.56,95% CI 0.34-0.92),急诊室等待时间也较短(中位数 4.0 小时对 4.7 小时)。在单变量模型(19.5% vs 15.7%;OR 1.30,95% CI:0.94-1.79)和多变量模型(aOR 1.08,95% CI:0.71-1.64)中,使用和未使用院前肾上腺素的患者入院率没有差异:院前注射肾上腺素降低了双相反应的发生几率,缩短了急诊室的住院时间,但并未减少急诊室过敏性休克患者的住院率。我们的研究结果表明,及时给予院前肾上腺素可改善患者的预后。
{"title":"Outcomes associated with prehospital epinephrine in adult and pediatric patients with anaphylaxis","authors":"Andrea L. Hlady MD, PhD ,&nbsp;Aliza F. Weinman MD, MPH ,&nbsp;Yuedan Zhang MD ,&nbsp;Aidan F. Mullan MA ,&nbsp;Ronna L. Campbell MD, PhD","doi":"10.1016/j.anai.2024.08.006","DOIUrl":"10.1016/j.anai.2024.08.006","url":null,"abstract":"<div><h3>Background</h3><div>Prompt epinephrine administration is important to improve outcomes in anaphylaxis.</div></div><div><h3>Objective</h3><div>To assess the impact of prehospital epinephrine on clinical outcomes of hospital admission, biphasic reactions, and emergency department (ED) length of stay (LOS) in a cohort of ED patients who had anaphylaxis including both children and adults.</div></div><div><h3>Methods</h3><div>We conducted a single-center prospective and retrospective cohort study of patients who had anaphylaxis from April 2008 to December 2022. Associations between prehospital epinephrine administration with biphasic reactions and ED LOS were assessed with univariable models and the association with ED disposition was assessed with both univariable and multivariable logistic regression.</div></div><div><h3>Results</h3><div>A total of 1107 patient visits were included for analysis. The median patient age was 29 (IQR: 14-50), 593 (53.6%) patients were of female sex, and 366 (33.1%) were younger than 18 years of age. Patients in the prehospital epinephrine group were also less likely to experience a biphasic reaction (5.4% vs 9.3%; odds ratio [OR] 0.56, 95% CI: 0.34-0.92) and had a decreased ED LOS (median 4.0 hours vs 4.7 hours). There was no difference in hospital admission between patients with and without prehospital epinephrine in both the univariable (19.5% vs 15.7%; OR 1.30, 95% CI: 0.94-1.79) and multivariable (adjusted OR 1.08, 95% CI: 0.71-1.64) models.</div></div><div><h3>Conclusion</h3><div>Prehospital epinephrine administration reduced the odds of a biphasic reaction and decreased ED LOS but did not reduce hospitalization in this cohort of ED patients who had anaphylaxis. Our findings suggest that timely administration of prehospital epinephrine is associated with improved patient outcomes.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 5","pages":"Pages 592-599.e8"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142001267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of type 2 inflammation 治疗 2 型炎症:慢性鼻炎伴鼻息肉和哮喘的靶向治疗。
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/j.anai.2024.08.020
William H. Eschenbacher MD
{"title":"Treatment of type 2 inflammation","authors":"William H. Eschenbacher MD","doi":"10.1016/j.anai.2024.08.020","DOIUrl":"10.1016/j.anai.2024.08.020","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 5","pages":"Pages 497-498"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142565089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ready, set, fly 准备,起飞
IF 5.8 2区 医学 Q1 ALLERGY Pub Date : 2024-11-01 DOI: 10.1016/j.anai.2024.08.025
Skylar Sloane BS , Lydia Su Yin Wong MBBS , Anna Nowak-Wegrzyn MD, PhD
{"title":"Ready, set, fly","authors":"Skylar Sloane BS ,&nbsp;Lydia Su Yin Wong MBBS ,&nbsp;Anna Nowak-Wegrzyn MD, PhD","doi":"10.1016/j.anai.2024.08.025","DOIUrl":"10.1016/j.anai.2024.08.025","url":null,"abstract":"","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 5","pages":"Pages 493-494"},"PeriodicalIF":5.8,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Allergy Asthma & Immunology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1